England

Anna Jewell
Policy & campaigning

Government U-turn on publication of 10 Year Cancer Plan – our statement

24 January 2023

Pancreatic Cancer UK's Director of Support, Research and Influencing, Anna Jewell, comments on the government's decision to scrap the 10 Year Cancer Plan for England

SABR treatment, Pancreatic cancer
Treatments

Introducing SABR treatment for pancreatic cancer

26 January 2022

In Autumn 2020, Pancreatic Cancer UK helped to submit a proposal to NHS England, asking them to commission a type of radiotherapy called SABR (Stereotactic Ablative Body Radiotherapy), for people with locally advanced pancreatic cancer (LAPC). Now, SABR treatment has been commissioned for rollout in England, thanks to a group of healthcare professionals and Pancreatic Cancer UK's Research Involvement Network (RIN).

Policy & campaigning

Our meeting with Jo Churchill, Cancer Minister for England

30 April 2021

An update on our meeting with Jo Churchill, the Cancer Minister, about the impact of the pandemic on pancreatic cancer.

Policy & campaigning

Our open letter to Jo Churchill, Cancer Minister for England

11 February 2021

An open letter to Jo Churchill, the Cancer Minister, raising our concerns about how COVID-19 is impacting pancreatic cancer treatment and care.

Policy & campaigning

NHS England publish National Cancer Recovery Plan for cancer services

16 December 2020

We comment on NHS England's National Cancer Recovery Plan, which aims to restore cancer services post pandemic

Research

NHS England announce new trial for a blood test to detect multiple cancers

27 November 2020

We comment on NHS England's announcement about a new trial for a blood test that could help improve early diagnosis for multiple cancers, including pancreatic cancer

Policy & campaigning

Spearheading the Less Survivable Cancers Taskforce

4 November 2020

Pancreatic Cancer survival rates have not changed in 50 years. We knew that if we were to make the decision makers listen, we would have to make our voices louder.